{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:38:55Z","timestamp":1792571935503,"version":"4.5.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":250,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chagas disease, caused by Trypanosoma cruzi, poses a significant global health burden. Current treatment relies solely on benznidazole and nifurtimox, both with limited efficacy and significant adverse effects. In vitro phenotype-based screening enables identification of alternative treatments. While epimastigote-based screening is not suitable for primary drug discovery, it provides valuable complementary data for compound evaluation. However, the lack of standardized experimental conditions across studies compromises reproducibility and inter-laboratory comparability. Here, we optimized experimental conditions for T. cruzi epimastigote drug susceptibility assays. Trypanosoma cruzi epimastigotes (strain Y) were cultured under systematically varied conditions to optimize medium composition, serum supplementation, medium replacement frequency, inoculum density, and treatment exposure time. Epimastigote growth peaked on day 8, declining thereafter. Low initial parasite inoculum showed reduced growth and high variability, while high parasite densities formed aggregates. Growth rates were similar across media, but Roswell Park Memorial Institute medium could promote trypomastigote-like forms. Fetal bovine serum (FBS) enhanced growth rates, with a positive correlation between serum concentration and proliferation. Three-day medium replacement maintained &amp;gt;98% epimastigotes. Benznidazole exhibited an IC50 of 16.61\u2009\u00b1\u20090.38\u2009\u00b5M under optimized conditions. Optimal conditions include: Liver Infusion Tryptose or Brain Heart Infusion medium with 10% FBS, medium replacement every 3 days, 1\u2009\u00d7\u2009106 parasites\/ml inoculum, and 72-h treatment at 28\u00b0C. The assay demonstrated robustness across microplate designs, producing consistent results with both U-bottom and flat-bottom 96-well plates. Under these optimized conditions, benznidazole serves as an effective positive control.<\/jats:p>","DOI":"10.1093\/biomethods\/bpag051","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:35:55Z","timestamp":1788867355000},"source":"Crossref","is-referenced-by-count":0,"title":["Optimization of an\n                    <i>in vitro<\/i>\n                    drug screening assay for anti-\n                    <i>Trypanosoma cruzi<\/i>\n                    activity using epimastigotes"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5437-5831","authenticated-orcid":false,"given":"Jhindy-Tatiana","family":"Perez","sequence":"first","affiliation":[{"name":"Universidad Nacional de Colombia, Sede Bogot\u00e1, Facultad de Ciencias, Departamento de Farmacia, Grupo de Investigaci\u00f3n FaMeTra (Farmacolog\u00eda de la Medicina Tradicional y Popular), Carrera 30 45-03, Bogot\u00e1 D.C. 111311, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1011-5157","authenticated-orcid":false,"given":"Mar\u00eda-Helena","family":"Arias","sequence":"additional","affiliation":[{"name":"Universidad Nacional de Colombia, Sede Bogot\u00e1, Facultad de Ciencias, Departamento de Farmacia, Grupo de Investigaci\u00f3n FaMeTra (Farmacolog\u00eda de la Medicina Tradicional y Popular), Carrera 30 45-03, Bogot\u00e1 D.C. 111311, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6055-0501","authenticated-orcid":false,"given":"Giovanny","family":"Garavito","sequence":"additional","affiliation":[{"name":"Universidad Nacional de Colombia, Sede Bogot\u00e1, Facultad de Ciencias, Departamento de Farmacia, Grupo de Investigaci\u00f3n FaMeTra (Farmacolog\u00eda de la Medicina Tradicional y Popular), Carrera 30 45-03, Bogot\u00e1 D.C. 111311, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"2026102103471186200_bpag051-B1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fpubh.2019.00166","article-title":"Chagas disease: from discovery to a worldwide health problem","volume":"7","author":"Lidani","year":"2019","journal-title":"Front Public Health"},{"key":"2026102103471186200_bpag051-B2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/j.semdp.2019.04.008","article-title":"Chagas disease as example of a reemerging parasite","volume":"36","author":"Guarner","year":"2019","journal-title":"Semin Diagn Pathol"},{"key":"2026102103471186200_bpag051-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prevetmed.2017.03.009","article-title":"Molecular and serological detection of Trypanosoma cruzi in dogs (Canis lupus familiaris) suggests potential transmission risk in areas of recent acute Chagas disease outbreaks in Colombia","volume":"141","author":"Jaimes-Due\u00f1ez","year":"2017","journal-title":"Prev Vet Med"},{"key":"2026102103471186200_bpag051-B4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.hgmx.2016.09.010","article-title":"Chagas disease: current perspectives on a forgotten disease","volume":"81","author":"\u00c1lvarez-Hern\u00e1ndez","year":"2018","journal-title":"Rev M\u00e9dica Hosp Gen M\u00e9xico"},{"key":"2026102103471186200_bpag051-B5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1590\/S0074-02762010000200022","article-title":"In vitro and in vivo experimental models for drug screening and development for Chagas disease","volume":"105","author":"Romanha","year":"2010","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2026102103471186200_bpag051-B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/genes11070722","article-title":"Of drugs and trypanosomatids: new tools and knowledge to reduce bottlenecks in drug discovery","volume":"11","author":"Bhattacharya","year":"2020","journal-title":"Genes (Basel)"},{"key":"2026102103471186200_bpag051-B7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jep.2006.04.003","article-title":"Anti-infective potential of natural products: how to develop a stronger in vitro \u00abproof-of-concept\u00bb","volume":"106","author":"Cos","year":"2006","journal-title":"J Ethnopharmacol"},{"key":"2026102103471186200_bpag051-B8","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1007\/s11033-019-04898-1","article-title":"Addressing the impact of different fetal bovine serum percentages on mesenchymal stem cells biological performance","volume":"46","author":"Khasawneh","year":"2019","journal-title":"Mol Biol Rep"},{"key":"2026102103471186200_bpag051-B9","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijantimicag.2020.105906","article-title":"Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review","volume":"55","author":"Santos","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"2026102103471186200_bpag051-B10","first-page":"7","article-title":"Epidemiol E Serv Saude Rev Sist Unico Saude Bras","volume":"25","author":"Dias","year":"2015","journal-title":"Braz Consensus Chagas Dis"},{"key":"2026102103471186200_bpag051-B11","doi-asserted-by":"crossref","first-page":"105688","DOI":"10.1016\/j.actatropica.2020.105688","article-title":"May the epimastigote form of Trypanosoma cruzi be infective?","volume":"212","author":"De Souza","year":"2020","journal-title":"Acta Trop"},{"key":"2026102103471186200_bpag051-B12","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.2174\/09298673113209990139","article-title":"Glycosomal targets for anti-trypanosomatid drug discovery","volume":"21","author":"Barros-Alvarez","year":"2014","journal-title":"Curr Med Chem"},{"key":"2026102103471186200_bpag051-B13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.freeradbiomed.2008.05.028","article-title":"Insights into the redox biology of Trypanosoma cruzi: trypanothione metabolism and oxidant detoxification","volume":"45","author":"Irigo\u00edn","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"2026102103471186200_bpag051-B14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/AAC.05135-11","article-title":"Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation","volume":"56","author":"Hall","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2026102103471186200_bpag051-B15","first-page":"1","article-title":"State-of-the-art in the drug discovery pathway for Chagas disease: a framework for drug development and target validation","volume":"14","author":"Gabald\u00f3n-Figueira","year":"2023","journal-title":"Res Rep Trop Med"},{"key":"2026102103471186200_bpag051-B16","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1007\/s00436-018-6084-3","article-title":"Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi","volume":"117","author":"Fonseca-Berzal","year":"2018","journal-title":"Parasitol Res"},{"key":"2026102103471186200_bpag051-B17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1590\/0037-8682-0285-2017","article-title":"Evaluation of in vitro anti-Trypanosoma cruzi activity of medications benznidazole, amiodarone hydrochloride, and their combination","volume":"51","author":"Louren\u00e7o","year":"2018","journal-title":"Rev Soc Bras Med Trop"},{"key":"2026102103471186200_bpag051-B18","doi-asserted-by":"crossref","DOI":"10.18273\/saluduis.57.e:25v57r04","article-title":"Experimental conditions for assessing anti-Trypanosoma cruzi (epimastigotes) activity in vitro: a scoping review","volume":"57","author":"Arias","year":"2025","journal-title":"Salud UIS"},{"key":"2026102103471186200_bpag051-B19","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/mmi.13653","article-title":"Recently differentiated epimastigotes from Trypanosoma cruzi are infective to the mammalian host","volume":"104","author":"Kessler","year":"2017","journal-title":"Mol Microbiol"},{"key":"2026102103471186200_bpag051-B20","doi-asserted-by":"crossref","first-page":"e0009269","DOI":"10.1371\/journal.pntd.0009269","article-title":"In vitro susceptibility of Trypanosoma cruzi discrete typing units (DTUs) to benznidazole: a systematic review and meta-analysis","volume":"15","author":"Vela","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"2026102103471186200_bpag051-B21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1590\/S0036-46652010000300012","article-title":"Origin of the \u00abY strain\u00bb of Trypanosoma cruzi","volume":"52","author":"Neto","year":"2010","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"2026102103471186200_bpag051-B22","doi-asserted-by":"crossref","first-page":"e1804","DOI":"10.1371\/journal.pntd.0001804","article-title":"Differential infectivity by the oral route of Trypanosoma cruzi lineages derived from Y strain. Traub-Csek\u00f6 YM, editor","volume":"6","author":"Cortez","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"2026102103471186200_bpag051-B23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1550-7408.1988.tb04140.x","article-title":"Trypanosoma cruzi\u202f: cell biological behavior of epimastigote and amastigote forms in axenic culture","volume":"35","author":"Engel","year":"1988","journal-title":"J Protozool"},{"key":"2026102103471186200_bpag051-B24","doi-asserted-by":"crossref","first-page":"e170404","DOI":"10.1590\/0074-02760170404","article-title":"Trypanosoma cruzi transcriptome during axenic epimastigote growth curve","volume":"113","author":"Santos","year":"2018","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2026102103471186200_bpag051-B25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4269\/ajtmh.16-0200","article-title":"Biological and molecular characterization of Trypanosoma cruzi strains from four states of Brazil","volume":"98","author":"Ribeiro","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2026102103471186200_bpag051-B26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1590\/S0074-02762001000100006","article-title":"Biological characterization of Trypanosoma cruzi strains","volume":"96","author":"Mart\u00ednez-D\u00edaz","year":"2001","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2026102103471186200_bpag051-B27","first-page":"6","article-title":"Cambios metab\u00f3licos durante la epimastigog\u00e9nesis in vitro de Trypanosoma cruzi","volume":"17","author":"Querales","year":"2013","journal-title":"Salus"},{"key":"2026102103471186200_bpag051-B28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jinsphys.2016.07.005","article-title":"Triatomine physiology in the context of trypanosome infection","volume":"97","author":"Guarneri","year":"2017","journal-title":"J Insect Physiol"},{"key":"2026102103471186200_bpag051-B29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.protis.2006.10.002","article-title":"Morphological events during the Trypanosoma cruzi cell cycle","volume":"158","author":"Elias","year":"2007","journal-title":"Protist"},{"key":"2026102103471186200_bpag051-B30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00436-012-2974-y","article-title":"Stationary phase in Trypanosoma cruzi epimastigotes as a preadaptive stage for metacyclogenesis","volume":"111","author":"Hern\u00e1ndez","year":"2012","journal-title":"Parasitol Res"},{"key":"2026102103471186200_bpag051-B31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5152\/tpd.2018.5750","article-title":"Comparison of reproduction densities in different liquid media of Trypanosoma cruzi and cryopreservation","volume":"42","author":"\u00d6zbilgin","year":"2018","journal-title":"Turk Parazitolojii Derg"},{"key":"2026102103471186200_bpag051-B32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yexcr.2018.02.017","article-title":"Human serum alters cell culture behavior and improves spheroid formation in comparison to fetal bovine serum","volume":"365","author":"Heger","year":"2018","journal-title":"Exp Cell Res"},{"key":"2026102103471186200_bpag051-B33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11745-010-3387-2","article-title":"Fetal bovine serum concentration affects \u03949 desaturase activity of Trypanosoma cruzi","volume":"45","author":"Villasuso","year":"2010","journal-title":"Lipids"},{"key":"2026102103471186200_bpag051-B34","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/jcb.21864","article-title":"Natural programmed cell death in T. cruzi epimastigotes maintained in axenic cultures","volume":"105","author":"Jimenez","year":"2008","journal-title":"J of Cellular Biochem"},{"key":"2026102103471186200_bpag051-B35","doi-asserted-by":"crossref","first-page":"e0186799","DOI":"10.1371\/journal.pone.0186799","article-title":"Influence of surface geometry on the culture of human cell lines: A comparative study using flat, round-bottom and v-shaped 96 well plates","volume":"12","author":"Shafaie","year":"2017","journal-title":"PLoS ONE"}],"container-title":["Biology Methods and Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biomethods\/advance-article-pdf\/doi\/10.1093\/biomethods\/bpag051\/70994236\/bpag051.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomethods\/article-pdf\/11\/1\/bpag051\/70994236\/bpag051.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomethods\/article-pdf\/11\/1\/bpag051\/70994236\/bpag051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:47:21Z","timestamp":1792568841000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biomethods\/article\/doi\/10.1093\/biomethods\/bpag051\/8787917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,12]]}},"URL":"https:\/\/doi.org\/10.1093\/biomethods\/bpag051","relation":{},"ISSN":["2396-8923"],"issn-type":[{"value":"2396-8923","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"bpag051"}}